ID CP2CI_HUMAN Reviewed; 490 AA. AC P33260; B2R8K2; Q16703; Q16751; Q4VAT5; Q6GRG1; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 07-JUN-2005, sequence version 3. DT 27-MAR-2024, entry version 199. DE RecName: Full=Cytochrome P450 2C18; DE EC=1.14.14.1 {ECO:0000269|PubMed:11093772}; DE AltName: Full=CYPIIC18; DE AltName: Full=Cytochrome P450-6b/29c; DE Flags: Precursor; GN Name=CYP2C18 {ECO:0000303|PubMed:11093772, GN ECO:0000312|HGNC:HGNC:2620}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-385. RC TISSUE=Liver; RX PubMed=2009263; DOI=10.1021/bi00227a012; RA Romkes M., Faletto M.B., Blaisdell J.A., Raucy J.L., Goldstein J.A.; RT "Cloning and expression of complementary DNAs for multiple members of the RT human cytochrome P450IIC subfamily."; RL Biochemistry 30:3247-3255(1991). RN [2] RP ERRATUM OF PUBMED:2009263, AND SEQUENCE REVISION. RX PubMed=8095407; DOI=10.1021/bi00056a025; RA Romkes M., Faletto M.B., Blaisdell J.A., Raucy J.L., Goldstein J.A.; RL Biochemistry 32:1390-1390(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-385. RC TISSUE=Liver; RX PubMed=8333835; DOI=10.1006/bbrc.1993.1803; RA de Morais S.M., Schweikl H., Blaisdell J., Goldstein J.A.; RT "Gene structure and upstream regulatory regions of human CYP2C9 and RT CYP2C18."; RL Biochem. Biophys. Res. Commun. 194:194-201(1993). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Stomach; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164054; DOI=10.1038/nature02462; RA Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., RA Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., RA Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., RA Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P., RA Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., RA Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., RA Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., RA Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., RA Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., RA Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., RA Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., RA Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., RA Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., RA McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., RA Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., RA Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., RA Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., RA Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., RA Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., RA Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., RA Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., RA Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 10."; RL Nature 429:375-381(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR RP LOCATION, AND PATHWAY. RX PubMed=11093772; DOI=10.1124/mol.58.6.1341; RA Marill J., Cresteil T., Lanotte M., Chabot G.G.; RT "Identification of human cytochrome P450s involved in the formation of all- RT trans-retinoic acid principal metabolites."; RL Mol. Pharmacol. 58:1341-1348(2000). RN [9] RP X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 72-80. RX PubMed=16963442; DOI=10.1074/jbc.m606755200; RA Archbold J.K., Macdonald W.A., Miles J.J., Brennan R.M., Kjer-Nielsen L., RA McCluskey J., Burrows S.R., Rossjohn J.; RT "Alloreactivity between disparate cognate and allogeneic pMHC-I complexes RT is the result of highly focused, peptide-dependent structural mimicry."; RL J. Biol. Chem. 281:34324-34332(2006). CC -!- FUNCTION: A cytochrome P450 monooxygenase involved in retinoid CC metabolism. Hydroxylates all trans-retinoic acid (atRA) to 4- CC hydroxyretinoate and may modulate atRA signaling and clearance. CC Mechanistically, uses molecular oxygen inserting one oxygen atom into a CC substrate, and reducing the second into a water molecule, with two CC electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH- CC ferrihemoprotein reductase). {ECO:0000269|PubMed:11093772}. CC -!- CATALYTIC ACTIVITY: CC Reaction=an organic molecule + O2 + reduced [NADPH--hemoprotein CC reductase] = an alcohol + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:17149, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:30879, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:142491; EC=1.14.14.1; CC Evidence={ECO:0000269|PubMed:11093772}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17150; CC Evidence={ECO:0000305|PubMed:11093772}; CC -!- CATALYTIC ACTIVITY: CC Reaction=all-trans-retinoate + O2 + reduced [NADPH--hemoprotein CC reductase] = all-trans-4-hydroxyretinoate + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:51984, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:35291, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:134178; CC Evidence={ECO:0000269|PubMed:11093772}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:51985; CC Evidence={ECO:0000305|PubMed:11093772}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=16 uM for all-trans-retinoate {ECO:0000269|PubMed:11093772}; CC Vmax=251 pmol/min/nmol enzyme toward all-trans-retinoate CC {ECO:0000269|PubMed:11093772}; CC -!- PATHWAY: Cofactor metabolism; retinol metabolism. CC {ECO:0000269|PubMed:11093772}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:11093772}; Peripheral membrane protein. Microsome CC membrane {ECO:0000269|PubMed:11093772}; Peripheral membrane protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P33260-1; Sequence=Displayed; CC Name=2; CC IsoId=P33260-2; Sequence=VSP_042520; CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M61853; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; M61856; AAB59356.1; -; mRNA. DR EMBL; L16876; AAA02630.1; -; Genomic_DNA. DR EMBL; L16871; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; L16872; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; L16869; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; L16870; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; L16875; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; L16873; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; L16874; AAA02630.1; JOINED; Genomic_DNA. DR EMBL; AK313403; BAG36199.1; -; mRNA. DR EMBL; AL583836; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471066; EAW50024.1; -; Genomic_DNA. DR EMBL; BC069666; AAH69666.1; -; mRNA. DR EMBL; BC096257; AAH96257.1; -; mRNA. DR EMBL; BC096258; AAH96258.1; -; mRNA. DR EMBL; BC096260; AAH96260.1; -; mRNA. DR CCDS; CCDS44460.1; -. [P33260-2] DR CCDS; CCDS7435.1; -. [P33260-1] DR PIR; A61269; A61269. DR RefSeq; NP_000763.1; NM_000772.2. [P33260-1] DR RefSeq; NP_001122397.1; NM_001128925.1. [P33260-2] DR PDB; 2CIK; X-ray; 1.75 A; C=72-80. DR PDB; 2H6P; X-ray; 1.90 A; C=72-80. DR PDBsum; 2CIK; -. DR PDBsum; 2H6P; -. DR AlphaFoldDB; P33260; -. DR SMR; P33260; -. DR BioGRID; 107938; 30. DR IntAct; P33260; 6. DR STRING; 9606.ENSP00000285979; -. DR BindingDB; P33260; -. DR ChEMBL; CHEMBL2408; -. DR DrugBank; DB08496; (R)-warfarin. DR DrugBank; DB14055; (S)-Warfarin. DR DrugBank; DB01424; Aminophenazone. DR DrugBank; DB01435; Antipyrine. DR DrugBank; DB00921; Buprenorphine. DR DrugBank; DB00349; Clobazam. DR DrugBank; DB01559; Clotiazepam. DR DrugBank; DB00531; Cyclophosphamide. DR DrugBank; DB00250; Dapsone. DR DrugBank; DB00829; Diazepam. DR DrugBank; DB00586; Diclofenac. DR DrugBank; DB09166; Etizolam. DR DrugBank; DB00986; Glycopyrronium. DR DrugBank; DB01181; Ifosfamide. DR DrugBank; DB00458; Imipramine. DR DrugBank; DB11757; Istradefylline. DR DrugBank; DB00448; Lansoprazole. DR DrugBank; DB00333; Methadone. DR DrugBank; DB07670; N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide. DR DrugBank; DB01183; Naloxone. DR DrugBank; DB00338; Omeprazole. DR DrugBank; DB00850; Perphenazine. DR DrugBank; DB01174; Phenobarbital. DR DrugBank; DB00252; Phenytoin. DR DrugBank; DB00818; Propofol. DR DrugBank; DB01124; Tolbutamide. DR DrugBank; DB00755; Tretinoin. DR DrugBank; DB00661; Verapamil. DR DrugBank; DB00682; Warfarin. DR GuidetoPHARMACOLOGY; 1327; -. DR SwissLipids; SLP:000001875; -. DR iPTMnet; P33260; -. DR PhosphoSitePlus; P33260; -. DR BioMuta; CYP2C18; -. DR DMDM; 67476954; -. DR MassIVE; P33260; -. DR PaxDb; 9606-ENSP00000285979; -. DR PeptideAtlas; P33260; -. DR ProteomicsDB; 54905; -. [P33260-1] DR ProteomicsDB; 54906; -. [P33260-2] DR Antibodypedia; 30592; 130 antibodies from 23 providers. DR DNASU; 1562; -. DR Ensembl; ENST00000285979.11; ENSP00000285979.6; ENSG00000108242.13. [P33260-1] DR Ensembl; ENST00000339022.6; ENSP00000341293.5; ENSG00000108242.13. [P33260-2] DR GeneID; 1562; -. DR KEGG; hsa:1562; -. DR MANE-Select; ENST00000285979.11; ENSP00000285979.6; NM_000772.3; NP_000763.1. DR UCSC; uc001kjv.6; human. [P33260-1] DR AGR; HGNC:2620; -. DR CTD; 1562; -. DR DisGeNET; 1562; -. DR GeneCards; CYP2C18; -. DR HGNC; HGNC:2620; CYP2C18. DR HPA; ENSG00000108242; Tissue enhanced (intestine, liver, stomach). DR MIM; 601131; gene. DR neXtProt; NX_P33260; -. DR OpenTargets; ENSG00000108242; -. DR PharmGKB; PA127; -. DR VEuPathDB; HostDB:ENSG00000108242; -. DR eggNOG; KOG0156; Eukaryota. DR GeneTree; ENSGT00940000162913; -. DR HOGENOM; CLU_001570_22_0_1; -. DR InParanoid; P33260; -. DR OMA; CWFNRVV; -. DR OrthoDB; 2900138at2759; -. DR PhylomeDB; P33260; -. DR TreeFam; TF352043; -. DR PathwayCommons; P33260; -. DR Reactome; R-HSA-211981; Xenobiotics. DR SABIO-RK; P33260; -. DR SignaLink; P33260; -. DR UniPathway; UPA00912; -. DR BioGRID-ORCS; 1562; 17 hits in 1145 CRISPR screens. DR ChiTaRS; CYP2C18; human. DR EvolutionaryTrace; P33260; -. DR GeneWiki; CYP2C18; -. DR GenomeRNAi; 1562; -. DR Pharos; P33260; Tchem. DR PRO; PR:P33260; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; P33260; Protein. DR Bgee; ENSG00000108242; Expressed in jejunal mucosa and 81 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA. DR GO; GO:0005886; C:plasma membrane; IDA:HPA. DR GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central. DR GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC. DR GO; GO:0020037; F:heme binding; IBA:GO_Central. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0071614; F:linoleic acid epoxygenase activity; IEA:Ensembl. DR GO; GO:0004497; F:monooxygenase activity; TAS:Reactome. DR GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IBA:GO_Central. DR GO; GO:0019825; F:oxygen binding; TAS:ProtInc. DR GO; GO:0008401; F:retinoic acid 4-hydroxylase activity; IDA:UniProtKB. DR GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central. DR GO; GO:0043651; P:linoleic acid metabolic process; IEA:Ensembl. DR GO; GO:0042573; P:retinoic acid metabolic process; IDA:UniProtKB. DR GO; GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway. DR GO; GO:0006805; P:xenobiotic metabolic process; IBA:GO_Central. DR CDD; cd20665; CYP2C-like; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24300:SF374; CYTOCHROME P450 2C18; 1. DR PANTHER; PTHR24300; CYTOCHROME P450 508A4-RELATED; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. DR Genevisible; P33260; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Endoplasmic reticulum; Heme; Iron; KW Lipid metabolism; Membrane; Metal-binding; Microsome; Monooxygenase; KW Oxidoreductase; Reference proteome; Signal. FT SIGNAL 1..25 FT /evidence="ECO:0000255" FT CHAIN 26..490 FT /note="Cytochrome P450 2C18" FT /evidence="ECO:0000255" FT /id="PRO_0000051707" FT BINDING 435 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250" FT VAR_SEQ 214..272 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_042520" FT VARIANT 385 FT /note="T -> M (in dbSNP:rs1126545)" FT /evidence="ECO:0000269|PubMed:2009263, FT ECO:0000269|PubMed:8333835" FT /id="VAR_001254" SQ SEQUENCE 490 AA; 55711 MW; C933CF31F078FD1E CRC64; MDPAVALVLC LSCLFLLSLW RQSSGRGRLP SGPTPLPIIG NILQLDVKDM SKSLTNFSKV YGPVFTVYFG LKPIVVLHGY EAVKEALIDH GEEFSGRGSF PVAEKVNKGL GILFSNGKRW KEIRRFCLMT LRNFGMGKRS IEDRVQEEAR CLVEELRKTN ASPCDPTFIL GCAPCNVICS VIFHDRFDYK DQRFLNLMEK FNENLRILSS PWIQVCNNFP ALIDYLPGSH NKIAENFAYI KSYVLERIKE HQESLDMNSA RDFIDCFLIK MEQEKHNQQS EFTVESLIAT VTDMFGAGTE TTSTTLRYGL LLLLKYPEVT AKVQEEIECV VGRNRSPCMQ DRSHMPYTDA VVHEIQRYID LLPTNLPHAV TCDVKFKNYL IPKGTTIITS LTSVLHNDKE FPNPEMFDPG HFLDKSGNFK KSDYFMPFSA GKRMCMGEGL ARMELFLFLT TILQNFNLKS QVDPKDIDIT PIANAFGRVP PLYQLCFIPV //